Factors influencing postoperative morbidity and mortality in patients treated with bleomycin.

PubWeight™: 1.04‹?› | Rank: Top 15%

🔗 View Article (PMC 1605498)

Published in Br Med J on June 24, 1978

Authors

P L Goldiner, G C Carlon, E Cvitkovic, O Schweizer, W S Howland

Articles by these authors

Major hepatic resection for neoplasia: personal experience in 108 patients. Ann Surg (1978) 2.80

Orthotopic and heterotopic liver homografts in man. Ann Surg (1970) 2.63

Major hepatic resection using vascular isolation and hypothermic perfusion. Ann Surg (1974) 2.30

Phase II study of oxaliplatin, fluorouracil, and folinic acid in locally advanced or metastatic gastric cancer patients. J Clin Oncol (2002) 2.15

Phase II study of ecteinascidin-743 in advanced pretreated soft tissue sarcoma patients. J Clin Oncol (2004) 2.15

High dose cis-platinum diammine dichloride: amelioration of renal toxicity by mannitol diuresis. Cancer (1977) 2.07

Oxaliplatin: a review of preclinical and clinical studies. Ann Oncol (1998) 2.03

The seventies evolution in liver surgery for cancer. Cancer (1981) 1.68

When the endotracheal tube will not pass over the flexible fiberoptic bronchoscope. Anesthesiology (1992) 1.66

Antitumor activity of oxaliplatin in combination with 5-fluorouracil and the thymidylate synthase inhibitor AG337 in human colon, breast and ovarian cancers. Anticancer Drugs (1997) 1.53

Randomized phase II study evaluating oxaliplatin alone, oxaliplatin combined with infusional 5-FU, and infusional 5-FU alone in advanced pancreatic carcinoma patients. Ann Oncol (2004) 1.51

Supraadditive effect of 2',2'-difluorodeoxycytidine (gemcitabine) in combination with oxaliplatin in human cancer cell lines. Cancer Chemother Pharmacol (1999) 1.40

Gemcitabine combined with oxaliplatin in advanced pancreatic adenocarcinoma: final results of a GERCOR multicenter phase II study. J Clin Oncol (2002) 1.39

Final report of a phase II study of chemotherapy with bleomycin, epirubicin, and cisplatin for locally advanced and metastatic/recurrent undifferentiated carcinoma of the nasopharyngeal type. Cancer J Sci Am (2006) 1.38

Oxaliplatin clinical activity: a review. Crit Rev Oncol Hematol (2000) 1.35

Phase I and pharmacokinetic study of ecteinascidin-743, a new marine compound, administered as a 24-hour continuous infusion in patients with solid tumors. J Clin Oncol (2001) 1.33

Nasopharyngeal cancer: epidemiology, staging, and treatment. Semin Oncol (1994) 1.31

Long-term disease-free survivors in metastatic undifferentiated carcinoma of nasopharyngeal type. J Clin Oncol (2000) 1.29

Ecteinascidin-743: a marine-derived compound in advanced, pretreated sarcoma patients--preliminary evidence of activity. J Clin Oncol (2001) 1.26

Early metastatic cancer of unknown primary origin at presentation. A clinical study of 302 consecutive autopsied patients. Arch Intern Med (1988) 1.25

The evolution of mature teratoma from malignant testicular tumors. Cancer (1977) 1.24

The renal pathology in clinical trials of cis-platinum (II) diamminedichloride. Cancer (1977) 1.24

Severe CPT-11 toxicity in patients with Gilbert's syndrome: two case reports. Ann Oncol (1997) 1.18

Improvement of cis-dichlorodiammineplatinum (NSC 119875): therapeutic index in an animal model. Cancer (1977) 1.16

Gunshot fractures in civilian practice. An evaluation of the results of limited surgical treatment. J Bone Joint Surg Am (1971) 1.15

Clinical experience with high frequency jet ventilation. Crit Care Med (1981) 1.13

Single agent activity of oxaliplatin in heavily pretreated advanced epithelial ovarian cancer. Ann Oncol (1996) 1.13

Prognostic value of clinicopathological parameters in head and neck squamous cell carcinoma: a prospective analysis. Br J Cancer (1996) 1.11

Clinical liver heterotopic (auxiliary) transplantation. Surgery (1973) 1.11

cis-Platinum ototoxicity. Clin Toxicol (1978) 1.11

Characterisation and clinical management of CPT-11 (irinotecan)-induced adverse events: the European perspective. Eur J Cancer (1996) 1.10

Undifferentiated nasopharyngeal cancer (UCNT): current diagnostic and therapeutic aspects. Int J Radiat Oncol Biol Phys (1995) 1.10

The recovery and intensive care unit, a clinical laboratory. Anesthesiology (1970) 1.06

CIS-Dichlorodiammineplatinum(II) in the treatment of epidermoid carcinoma of the head and neck. Cancer Treat Rep (1977) 1.06

Coagulation abnormalities associated with liver transplantation. Surgery (1970) 1.05

High-frequency jet ventilation. A prospective randomized evaluation. Chest (1983) 1.05

Sequential bilateral germ cell tumors of the testis despite interval chemotherapy. J Urol (1979) 1.05

Pathophysiology and therapy of irinotecan-induced delayed-onset diarrhea in patients with advanced colorectal cancer: a prospective assessment. J Clin Oncol (1998) 1.03

Prediction equation estimates of creatinine clearance in the intensive care unit. Intensive Care Med (1993) 1.03

High-frequency positive-pressure ventilation in management of a patient with bronchopleural fistula. Anesthesiology (1980) 1.02

Small-cell carcinoma of the esophagus: treatment by chemotherapy alone. Cancer (1980) 1.01

Relationship of right bundle-branch block and marked left axis deviation to complete heart block during general anesthesia. Anesthesiology (1976) 1.01

Oxaliplatin/cisplatin (L-OHP/CDDP) combination in heavily pretreated ovarian cancer. Eur J Cancer (1997) 1.00

A comparison of intraoperative measurements of coagulation. Anesth Analg (1974) 1.00

A comparison of pulmonary function tests for postthoracotomy pain using cryoanalgesia and transcutaneous nerve stimulation. Ann Thorac Surg (1986) 0.99

Neurological complications of malignant germ cell tumors of testis: biology of brain metastases (I). Cancer (1979) 0.99

Combination of oxaliplatin plus irinotecan in patients with gastrointestinal tumors: results of two independent phase I studies with pharmacokinetics. J Clin Oncol (1999) 0.97

VAB-4 combination chemotherapy in the treatment of metastatic testis tumors. Cancer (1981) 0.96

Pharmacokinetics and pharmacodynamics of the novel marine-derived anticancer agent ecteinascidin 743 in a phase I dose-finding study. Clin Cancer Res (2000) 0.96

Treatment of advanced squamous cell carcinoma of the skin with cisplatin, 5-fluorouracil, and bleomycin. Cancer (1990) 0.96

Urinary creatinine excretion in the ICU: low excretion does not mean inadequate collection. Am J Crit Care (1993) 0.96

Proceedings: Hypercoagulability. Thrombelastographic monitoring during extensive hepatic surgery. Arch Surg (1974) 0.95

Phase II study of cisplatin and 120-hour continuous infusion of 5-fluorouracil in patients with advanced pancreatic adenocarcinoma. Ann Oncol (1993) 0.95

Biology and treatment of nasopharyngeal cancer. Curr Opin Oncol (1995) 0.95

Filter for prevention of microembolism during massive transfusions. Anesth Analg (1972) 0.94

A new concept for hepatic lobectomy. Experimental studies and clinical application. Arch Surg (1971) 0.94

Undifferentiated carcinoma of nasopharyngeal type of tonsil. Arch Otolaryngol Head Neck Surg (1989) 0.93

Antiproliferative effects of sapacitabine (CYC682), a novel 2'-deoxycytidine-derivative, in human cancer cells. Br J Cancer (2007) 0.93

Just say no. Crit Care Med (1989) 0.93

Long-term prognostic and predictive factors in 107 stage II/III breast cancer patients treated with anthracycline-based neoadjuvant chemotherapy. Br J Cancer (1997) 0.92

Tumor vascularization, mitotic index, histopathologic grade, and DNA ploidy in the assessment of 114 head and neck squamous cell carcinomas. Cancer (1995) 0.92

Cellular pharmacology of the combination of the DNA topoisomerase I inhibitor SN-38 and the diaminocyclohexane platinum derivative oxaliplatin. Clin Cancer Res (1999) 0.92

Influence of pretreatment clinical characteristics on the response rate to mitomycin/vindesine/cisplatin (MVP) in unresectable non-small cell lung cancer. ATTIT (Association pour le Traitement des Tumeurs Intra-Thoraciques). Eur J Cancer (1991) 0.91

Factors predicting for efficacy and safety of docetaxel in a compassionate-use cohort of 825 heavily pretreated advanced breast cancer patients. J Clin Oncol (2000) 0.90

Modulation of stimulation-evoked release of newly formed acetylcholine from mouse hemidiaphragm preparation. Naunyn Schmiedebergs Arch Pharmacol (1987) 0.90

Heterogeneity of presynaptic muscarinic receptors involved in modulation of transmitter release. Neuroscience (1989) 0.90

Irinotecan-induced immune thrombocytopenia. Ann Oncol (1998) 0.89

Chemotherapy of metastatic and/or recurrent undifferentiated nasopharyngeal carcinoma with cisplatin, bleomycin, and fluorouracil. J Clin Oncol (1991) 0.89

Pulmonary embolus-induced disseminated intravascular coagulation. Crit Care Med (1987) 0.89

Tidal volume and airway pressure on high frequency jet ventilation. Crit Care Med (1983) 0.88

The hazards of anesthesia and surgery in bleomycin-treated patients. Semin Oncol (1979) 0.88

Technical aspects and clinical implications of high frequency jet ventilation with a solenoid valve. Crit Care Med (1981) 0.88

Dose-finding study of docetaxel and doxorubicin in first-line treatment of patients with metastatic breast cancer. Ann Oncol (1999) 0.88

Cost-effectiveness of monoclonal antibodies to gram-negative endotoxin in the treatment of gram-negative sepsis in ICU patients. JAMA (1993) 0.88

Recurrent and/or metastatic head and neck squamous cell carcinoma: a clinical, univariate and multivariate analysis of response and survival with cisplatin-based chemotherapy. Laryngoscope (1991) 0.88

Phase II study of oxaliplatin in poor-prognosis non-small cell lung cancer (NSCLC). ATTIT. Association pour le Traitement des Tumeurs Intra Thoraciques. Eur J Cancer (1998) 0.88

Oxaliplatin plus vinorelbine in advanced non-small-cell lung cancer: final results of a multicenter phase II study. Ann Oncol (2002) 0.87

Clotting problems during surgery. Surg Clin North Am (1969) 0.87

Acute respiratory failure in cancer patients. Curr Probl Cancer (1979) 0.87

Germ cell tumors (II): VAB II in metastatic testicular cancer. Cancer (1978) 0.87

Oxaliplatin and paclitaxel combination in patients with platinum-pretreated ovarian carcinoma: an investigator-originated compassionate-use experience. Ann Oncol (1999) 0.87

The cardiovascular effects of low levels of ionized calcium during massive transfusion. Surg Gynecol Obstet (1977) 0.87

Single agent and combination studies of pralatrexate and molecular correlates of sensitivity. Br J Cancer (2010) 0.87

Presynaptic interaction between vagal and sympathetic innervation in the heart: modulation of acetylcholine and noradrenaline release. J Auton Nerv Syst (1991) 0.86

Intraoperative physiologic monitoring and management during hepatic lobectomy using the liver isolation-perfusion technic. Am J Surg (1975) 0.86

Hypoxemia during hemodialysis. Crit Care Med (1979) 0.86

The anatomical location of the transesophageal echocardiographic transducer during a short-axis view of the left ventricle. J Cardiothorac Anesth (1990) 0.86

The effect of buffering on the mortality of massive blood replacement. Surg Gynecol Obstet (1965) 0.86

The effect of ether and halothane on blood levels of glucose, pyruvate, lactate and metabolites of the tricarboxylic acid cycle in normotensive patients during operation. Anesthesiology (1967) 0.86